Biggest News Aggregation in the World
📰 Slow Release News

Page 2 - Slow Release News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Slow Release. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Oncorena Receives Approval of First in Patient Trial with Orellanine as a Potential Breakthrough Therapy in Metastatic Renal Cancer Patients | Small Molecules

Hits: 574 LUND, Sweden I March 1, 2021 I Oncorena, dedicated to developing a unique and potential breakthrough therapy for metastatic renal cancer, today announces the Swedish Medical Products Agencys approval of the Phase 1/2 of First in Patient trial of the first-in-class compound, orellanine in patients with metastatic renal cancer in dialysis. Preclinical evidence shows that orellanine, a well known fungus toxin, specifically exerts powerful anti-tumor effects on metastatic renal cancer...
Lars Grundemar Andreas Segerros Centre For Clinical Cancer Karolinska University Hospital Swedish Medical Products Agency Oncorena Receives Approval

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science